from Nevada, which did not meet criteria in 2011. This report includes all cases of malignant † cancer diagnosed among persons aged <20 years; it includes first primary cases only and excludes recurrent cases. Diagnosis histology and primary site were grouped according to the International Classification of Childhood Cancer (ICCC). § Pediatric cancer rates were expressed per 1 million persons and were age-adjusted to the 2000 U.S. standard population. ¶ Rates were estimated by sex, age group, race/ethnicity, state, U.S. Census region,** county-level economic status, countylevel rural/urban classification, and ICCC group.
During 2003-2014, CDC identified 171,432 new cases of pediatric cancer (Table 1) . Overall incidence was 173.7 cases per 1 million population. The cancer types with the highest incidence rates were leukemias (45.7 per 1 million), brain tumors (30.9), and lymphomas (26.2). Rates were higher in males (181.5) than in females (165.5) and in persons aged 0-4 years (228.9) and 15-19 years (213.3) than in persons aged 5-9 years (122.6) and 10-14 years (133.0). Among all racial/ ethnic groups, the highest incidence rate was among whites (184.4), and the lowest was among blacks (133.3).
Rates were highest in the Northeast U.S. Census region, followed by the Midwest, the West, and the South. Rates were highest in the Northeast across all age groups and among whites and blacks. Among Hispanics, rates were highest in the South. Pediatric cancer incidence rates were highest in the 25% of counties with the highest economic status and were higher in metropolitan areas with populations ≥1 million than in nonmetropolitan areas.
By state, pediatric cancer incidence rates ranged from 145. 2 
Massachusetts 3,584 181.5 (175.6-187.5) 
Delaware 504 180.9 (165.5-197.5) Pediatric cancer incidence rates varied by state within each cancer type (Figure) . Incidence rates were highest in the West for leukemias, myeloproliferative diseases, and myelodysplastic diseases (ICCC group I) and in the Northeast for lymphomas and reticuloendothelial neoplasms (group II) and central nervous system cancers (group III). Rates were also highest in the Northeast for neuroblastoma, retinoblastoma, bone tumors, soft tissue sarcomas, and thyroid cancer (Supplementary  Table 2 , https://stacks.cdc.gov/view/cdc/53586). Renal cancer rates were highest in the Northeast and South; hepatic tumor rates were highest in the Northeast and West. Germ cell tumor rates were highest in the West (Supplementary Table 2 , https:// stacks.cdc.gov/view/cdc/53586).
Discussion
This study used recent data with greater population coverage than past studies (4,5) to document geographic variation in pediatric cancer incidence rates by sex, age, type, and race/ ethnicity. Consistent with past reports (1,4,5 ), pediatric cancer rates were highest in males, persons aged 0-4 years and 15-19 years, whites, and the Northeast U.S. Census region. Rates were highest in metropolitan areas with populations ≥1 million; state-based rates were highest in New Hampshire, DC, and New Jersey.
A strength of this report is the use of extensive populationbased surveillance data (>99% coverage § § ), which permits a detailed description of state-based cancer incidence variation. Geographic variation in rates might account for differences in results from previous studies that were based on different populations such as state data (2,3), SEER registries (which cover 9%-28% of the U.S. population), ¶ ¶ or other large data sets (6) . A 2016 study specific to Delaware assessed pediatric cancer incidence by demographic group and ZIP Code; the study commented on local environmental exposures and possible incidence disparities based upon sex, age, race/ethnicity, geographic location, and economic status (2) . USCS data provide states with a standardized way to gauge whether local pediatric cancer incidence rates differ relative to other states and might prompt states to conduct investigations similar to the one performed in Delaware.
Geographic variation in pediatric cancer incidence might be influenced by several factors.*** First, variation in childhood cancer incidence might be related to differences in exposures to carcinogenic chemicals (e.g., air pollution, secondhand smoke, food, or drinking water) or radiation (7). Second, genetic variation in certain populations (e.g., prevalence of cancer predisposition genes) (2,4,5) might contribute to geographic differences in cancer incidence. Third, the rates of ¶ ¶ https://seer.cancer.gov/registries/data.html. *** https://www.cdc.gov/cancer/npcr/uscs/data/00_guidance_include.htm.
Summary
What is already known about this topic?
Past research on nationwide pediatric cancer incidence described differences by U.S. Census region but did not provide state-level estimates.
What is added by this report?
During 2003-2014, the pediatric cancer rate was highest in the Northeast, lowest in the South, and highest in metropolitan areas with populations ≥1 million and counties in the top 25% economic status. Incidence rates by state ranged from 145 to 206 per million and were highest in New Hampshire, the District of Columbia, and New Jersey. The highest rate of leukemia was in the West; the highest rates of lymphoma and brain cancer were in the Northeast.
What are the implications for public health practice?
Knowledge of these geographic differences in childhood cancer incidence can be used to enhance provider awareness, treatment capacity, survivorship care, and cancer surveillance.
certain cancer types might vary by race/ethnicity. For example, Hispanic children have the highest rate of the most common type of leukemia, pediatric acute lymphoblastic leukemia, and states with a higher proportion of Hispanics might have higher rates of acute lymphoblastic leukemia (8) . Fourth, incidence of some types of cancer (e.g., thyroid carcinoma) might be related to enhanced detection and access to care, which can vary by geographic location (5, 9) .
In addition, geographic variation might be affected by age, economic status, or rural/urban classification (4, 8, 10) . Similar to the findings from this report, recent data detailing adult cancers also indicate that the highest cancer incidence rates are in the Northeast (10) . Rates of cancer types mostly affecting adults also varied by rural/urban status; some of these differences in adults might be related to factors such as obesity or smoking (10), which might or might not also explain rural/ urban variation in pediatric cancer.
The findings in this report are subject to at least three limitations. First, Nevada was excluded because data for 2011 did not meet quality criteria, which limits the representativeness of the findings. Second, differences in diagnosis and cancer reporting among states might contribute to variation in cancer incidence rates (8) . For example, states that were early adopters of electronic pathology reporting might report increased rates because of increased case ascertainment compared with other states. Finally, misrepresentation of race and ethnicity might exist; rate numerators might underestimate American Indians, Alaska Natives, and Hispanics, which could artificially lower rates among these groups; and U.S. Census populations used in rate denominators might undercount children and Hispanics, which could artificially increase rates in these populations (8) . † † † Knowledge of pediatric cancer incidence variation by state and cancer type can prompt local and state cancer registries to evaluate reporting and diagnostic standards. Understanding geographic variation in incidence rates can help cancer control planners and clinicians address obstacles in access to care, which is especially relevant to states with large distances to pediatric oncology centers (3). Because 5-year pediatric cancer survival is >80%, and most cancer survivors require close monitoring by specialists throughout life (5), state-specific data by cancer type and patient age might help public health planners address ongoing chronic care needs. In addition, state-specific data by cancer type and patient age might help clinical trial organizers predict patient accrual. Finally, health care practitioners and researchers can use these data to guide investigations related to causes of pediatric cancer incidence variation (2, 3) . Continued surveillance will be needed to further validate findings and track geographic incidence patterns over time. † † † https://www.cdc.gov/cancer/npcr/uscs/technical_notes/interpreting/race.htm.
